Health Condition 1: null- Diagnosed cases of urticaria on treatment not getting relief with conventional treatment will be given Omalizumab injection an approved drug for the same
Conditions
Interventions
None listed
Sponsors
Command Hospital Air Force
Eligibility
Inclusion criteria
Inclusion criteria: All patients reported to Dermatology department of CHAF Bangalore and were diagnosed as a case of chronic spontaneous urticaria (characterized by itchy hives that occur for at least six weeks with or without angioedema but have no apparent trigger) eliminating all possible causes for urticaria after through history taking and investigations and were symptomatic with moderate to severe urticaria (UAS-7 >15) even after double the dose of anti-histamines (Tab Fexofenadine 360 mg)comprised the study group. Subjects who were willing and able to comply with all follow-up requirements
Exclusion criteria
Exclusion criteria: Clearly defined underlying cause of urticaria Patient previously treated with Omalizumab History of malignancy Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in UAS 7 score (score to measure severity of urticaria)Timepoint: 24 Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in UAS 7 score (score to measure severity of urticaria)Timepoint: 4,8,12,24 Weeks | — |
Countries
India
Contacts
Public ContactSandeep Lal V
Command Hospital Air Force
Outcome results
None listed